• Journal of Chest Surgery
• /
• 제30권6호
• /
• pp.613-616
• /
• 1997

저자들은 말기 확장성 심부전을 앓아온 58세의 여자환자에게 좌심실 내경을 줄여주는 좌심실개조수술을 시행하여 좌심실기능의 향상을 보았기에 증례보고를 하고자 한다. 본 환자는 1996년 9월에 심부전으로 인한 호흡곤란(NYHA 기능 4도)과 사지부종을 주소로 입원하였다. 입원시 심초음파검사상 좌심실 구축률 15%, 좌 심실 말기이완기 내경이 80mm, 승모판 폐쇄부전 4도, 삼첨판 폐쇄부전 2도였고 심박출량이 1.5L/min였고 심 박출계수는 1.0 L/min/m2 있단 이 환자에게 전방유두근과 후방유두근 사이의 좌심실 측벽을 절제하고 승모 판과 삼첨판 성형술을 실시하는 좌심실개조수술을 시행하였다. 술후 심초음파검사와 혈역학적 평가결과, 좌 심실 구축력 35%, 좌심실 말기이완기내경 50m였고, 승모판 기능 및 삼첨판 기능은 완벽하였다. 심박출량은 2.3L/ms 였고 심박출계수는 2.3umi m2였고 환자의 mID기능은 1도였다.

• Journal of Chest Surgery
• /
• 제52권1호
• /
• pp.16-24
• /
• 2019

Background: Optimal graft selection for coronary artery bypass grafting (CABG) in patients with severe left ventricular (LV) dysfunction remains debatable. We report an analysis of our experiences of isolated CABG in patients with severe LV dysfunction and the impact of graft strategy on long-term outcomes. Methods: We analyzed 209 patients with severe LV dysfunction (ejection fraction [EF] <30%) who underwent primary isolated CABG. Of these, 169 were revascularized with a bilateral internal thoracic arterial (ITA) graft (BITA group) and 40 were revascularized with a single ITA graft (SITA group). The mean follow-up duration was $22{\pm}32$ months. Results: There were 18 early deaths (8.6%). Overall survival at 5 years was 66.7%. The rate of freedom from cardiac-related death at 5 years was 74.1%, and was significantly higher in patients who underwent off-pump CABG (p=0.005) and in the BITA group (p=0.023). Multivariate analysis demonstrated that old age (hazard ratio [HR], 2.548; 95% confidence interval [CI], 1.134-5.762; p=0.024), off-pump CABG (HR, 0.245; 95% CI, 0.090-0.661; p=0.006), and BITA grafts (HR, 0.333; 95% CI, 0.146-0.757; p=0.009) were correlated with cardiac mortality. Conclusion: CABG in patients with severe LV dysfunction (EF <30%) showed reasonable long-term outcomes. The rate of freedom from cardiac-related death was significantly higher in patients who underwent off-pump CABG and in the BITA group. Off-pump BITA grafting strategies can be accepted as a viable primary option in patients with severe LV dysfunction if performed by an experienced surgeon.

• 대한핵의학회:학술대회논문집
• /
• 대한핵의학회 2000년도 2nd Korea-China Congress of Nuclear Medicine and 39th Annual Spring Meeting if the Korea SOciety Nuclear Medicine
• /
• pp.77.1-77.1
• /
• 2000

• 대한핵의학회지
• /
• 제36권6호
• /
• pp.381-391
• /
• 2002

목적: 심질환의 예후 인자로 알려진 좌심근 질량 및 좌심실 구혈률을 구할 수 있는 게이트 심근관류 스펙트는 관류결손에 의해 영향을 받을 수 있다. 또한 관류결손을 일으키는 심혈관질환은 안정시와 부하후 좌심실 기능에 영향을 줄 수 있다. 본 연구는 심근관류 스펙트상 관류결손을 가진 환자를 대상으로하여, 첫째 관류 결손의 크기와 가역성 여부에 따른 안정시와 부하 후 게이트 심근관류 스펙트로 구한 좌심근 질량의 차이를 알아 보았으며, 둘째, 관류결손의 가역성 여부에 따른 안정시와 부하 후 게이트 심근관류 스펙트로 얻은 좌심실 용적과 좌심실 구혈률의 상관성 및 차이를 비교해 보았다. 대상 및 방법: 심근관류스펙트상관류 결손이 있는환자 46명을 대상으로 하였다. 대상 환자 가운데 남자가 34명(73.9%)이었고 평균연령은 $64{\pm}9$세였으며, 40명(87.0%)은 가역성 관류결손이었다. 게이트 심근관류 스펙트는 740MBq의 Tc-99m MIBI를 투여한 후 이중헤드 감마카메라(Vertex Plus, ADAC,USA)를 이용하여 영상자료를 얻었다. 좌심근 질량, 이완기말/수축기말 좌심실 용적 및 좌심실 구혈률은 AutoQUANT 프로그램을 이용하여 구하였다. 결과: 안정시와 부하 후 게이트 심근관류 스펙트로 구한 좌심근 질량은 뛰어난 상관성을 나타내었다. 가역적 관류결손 환자보다 고정 관류결손 환자가, 관류 결손의 크기가 20%미만인 환자가 관류 결손크기가 20% 이상인 환자보다 두 값 사이에 더 높은 상관성이 있었다. 고정 관류결손을 가진 환자는 안정시와 부하 후 게이트 심근관류 스펙트에서 얻은 좌심실 이완기말 용적, 좌심실 수축기말 용적, 좌심실 구혈률에 차이가 없었으나, 가역적 관류결손을 가진 환자에서는 안정시와 부하후 게이트 심근관류 스펙트에서 얻은 좌심실 구혈률에 유의한 차이가 있었다. 가역적 관류결손 환자 40명 가운데 10명(25%)에서는 부하후 게이트 심근관류 스펙트에서 구한 좌심실 구혈률이 안정시에 구한 좌심실 구혈률보다 5%이상 낮았다. 고정관류 결손환자는 가역적 관류 결손환자에 비해 안정시와 부하 후 좌심실 용적과 구혈률에 더 높은 상관성을 나타내었다. 결론: 관류결손은 게이트 심근관류 스펙트를 이용한 좌심근 질량측정에 영향을 미칠 수 있으며, 고정 관류 결손을 가진 환자 보다 가역적 관류 결손을 가진 환자에서 심근부하 후 좌심실 구혈률 감소가 더 빈번하게 발생됨을 알 수 있었다.

• Korean Circulation Journal
• /
• 제53권9호
• /
• pp.606-618
• /
• 2023

Background and Objectives: The prognostic or safety implication of renin-angiotensin-aldosterone system inhibitors (RASi) in hypertrophic cardiomyopathy (HCM) are not well established, mainly due to concerns regarding left ventricular outflow tract (LVOT) obstruction aggravation. We investigated the implications of RASi in a sizable number of HCM patients. Methods: We enrolled 2,104 consecutive patients diagnosed with HCM in 2 tertiary university hospitals and followed up for five years. RASi use was defined as the administration of RASi after diagnostic confirmation of HCM. The primary and secondary outcomes were all-cause mortality and hospitalization for heart failure (HHF). Results: RASi were prescribed to 762 patients (36.2%). During a median follow-up of 48.1 months, 112 patients (5.3%) died, and 94 patients (4.5%) experienced HHF. Patients using RASi had less favorable baseline characteristics than those not using RASi, such as older age, more frequent history of comorbidities, and lower ejection fraction. Nonetheless, there was no difference in clinical outcomes between patients with and without RASi use (log-rank p=0.368 for all-cause mortality and log-rank p=0.443 for HHF). In multivariable analysis, patients taking RASi showed a comparable risk of all-cause mortality (hazard ratio [HR], 0.70, 95% confidence interval [CI], 0.43-1.14, p=0.150) and HHF (HR, 1.03, 95% CI, 0.63-1.70, p=0.900). In the subgroup analysis, there was no significant interaction of RASi use between subgroups stratified by LVOT obstruction, left ventricular (LV) ejection fraction, or maximal LV wall thickness. Conclusions: RASi use was not associated with worse clinical outcomes. It might be safely administered in patients with HCM if clinically indicated.

• Clinical and Experimental Pediatrics
• /
• 제59권4호
• /
• pp.190-195
• /
• 2016

Purpose: Severe aplastic anemia (SAA), a fatal disease, requires multiple transfusion, immunosuppressive therapy, and finally, hematopoietic stem cell transplantation (HSCT) as the definitive treatment. We hypothesized that iron overloading associated with multiple transfusions and HSCT-related complications may adversely affect cardiac function. Left ventricular (LV) function was assessed in children after HSCT for SAA. Methods: Forty-six consecutive patients with a median age of 9.8 years (range, 1.5-18 years), who received HSCT for SAA and who underwent comprehensive echocardiography before and after HSCT, were included in this study. The data of LV functional parameters obtained using conventional echocardiography, tissue Doppler imaging (TDI), and speckle-tracking echocardiography (STE) were collected from pre- and post-HSCT echocardiography. These data were compared to those of 40 age-matched normal controls. Results: In patients, the LV ejection fraction, shortening fraction, end-diastolic dimension, mitral early diastolic E velocity, TDI mitral septal E' velocity, and STE LV longitudinal systolic strain rate (SSR) decreased significantly after HSCT. Compared to normal controls, patients had significantly lower post-HSCT early diastolic E velocity and E/A ratio. On STE, patients had significantly decreased LV deformational parameters including LV longitudinal systolic strain (SS), SSR, and diastolic SR (DSR), and circumferential SS and DSR. Serum ferritin levels showed weak but significant correlations (P<0.05) with LV longitudinal SS and SSR and circumferential SS and DSR. Conclusion: Subclinical LV dysfunction is evident in patients after HSCT for SAA, and was associated with increased iron load. Serial monitoring of cardiac function is mandatory in this population.

• Journal of Chest Surgery
• /
• 제49권5호
• /
• pp.350-355
• /
• 2016

Background: Mitral stenosis (MS) remains one of the important heart diseases. There are many factors that influence the clinical outcomes, and little is known about how left ventricular (LV) dysfunction clinically affects the prognosis of the patient with MS after mitral valve replacement (MVR). We reviewed our clinical experiences of MVR in patients with MS who had LV dysfunction. Methods: Between January 1991 and January 2013, 110 patients with MS who underwent MVR were analyzed and divided into two groups according to ejection fraction (EF). Group 1 ($EF{\leq}45%$) included 13 patients and group 2 (EF>45%) included 97 patients. Results: Thromboembolism occurred in 8 patients after MVR (group 1: n=3, 23.1%; group 2: n=5, 5.2%) and its incidence was significantly higher in group 1 than in group 2 (p=0.014). There were 3 deaths each in groups 1 and 2 during follow-up. The overall rate of cardiac-related death in group 1 was significantly higher than in group 2 (group 1: n=3, 23.1%; group 2: n=3, 3.1%; p=0.007). The cumulative survival rate at 1 and 15 years was 83.9% and 69.9% in group 1 and 97.9% and 96.3% in group 2 (p=0.004). The Cox regression analysis revealed that survival was significantly associated with postoperative stroke (p=0.011, odds ratio=10.304). Conclusion: This study identified postoperative stroke as an adverse prognostic factor in patients with MS after MVR, and a s more prevalent in patients with LV dysfunction. Postoperative stroke should be reduced to improve clinical outcomes for patients. Preventive care should be made in multiple ways, such as management of LV dysfunction, atrial fibrillation, and anticoagulation.

• Advances in biomechanics and applications
• /
• 제1권1호
• /
• pp.41-55
• /
• 2014

Acellular intra-myocardial biomaterial injections have been shown to be therapeutically beneficial in inhibiting ventricular remodelling of myocardial infarction (MI). Based on a biventricular canine cardiac geometry, various finite element models were developed that comprised an ischemic (II) or scarred infarct (SDI) in left ventricular (LV) antero-apical region, without and with intra-myocardial biomaterial injectate in layered (L) and bulk (B) distribution. Changes in myocardial properties and LV geometry were implemented corresponding to infarct stage (tissue softening vs. stiffening, infarct thinning, and cavity dilation) and injectate (infarct thickening). The layered and bulk injectate increased ejection fraction of the infarcted LV by 77% (II+L) and 25% (II+B) at the ischemic stage and by 61% (SDI+L) and 63% (SDI+B) at the remodelling stage. The injectates decreased the mean end-systolic myofibre stress in the infarct by 99% (II+L), 97% (II+B), 70% (SDI+L) and 36% (SDI+B). The bulk injectate was slightly more effective in improving LV function at the remodelling stage whereas the layered injectate was superior in functional improvement at ischemic stage and in reduction of wall stress at ischemic and remodelling stage. These findings may stimulate and guide further research towards tailoring acellular biomaterial injectate therapies for MI.

• Journal of Chest Surgery
• /
• 제41권4호
• /
• pp.439-446
• /
• 2008

배경: 본 연구의 목적은 좌심실 수축기능, 용적, 질량과 QT dispersion간의 관계를 알아보고, 관상동맥 협착이 있는 환자와 없는 환자에서 비교하는 것이다. 대상 및 방법: 174명의 ST분절 및 심근효소 이상소견이 없는 전형적인 안정성 협심증을 호소하는 환자들을 대상으로 하였다. Group I은 심혈관 촬영상 관상동맥 협착이 50%이상(n=101), Group II는 심혈관 촬영상 관상동맥 협착이 50%이하(n=73)인 환자로 나누었다. 심혈관 촬영 전에 좌심실 구출율, 용적, 질량을 심초음파로 측정하였고 QT dispersion측정을 위해 12-lead 심전도를 측정하였다. 결과: QT dispersion은 Group I에서 Group II보다 유의하게 길었다(39.8 ms vs. 33.3 ms; p<0.05). 모든 환자에서 좌심실용적, 질량은 QT dispersion과 통계학적으로 유의한 상관관계가 있었으며, 좌심실 질량은 유일한 독립적 관계요소였다.(p<0.05). 그런데 Group I에서만 보면 초음파상에 나타난 어떤 결과도 QT dispersion과 유의한 상관 관계가 없었으며, Group II에서는 좌심실 용적, 질량은 QT dispersion과 유의한 상관관계가 있었으며, 좌심실 질량은 여전히 독립적 관계 요소였다(p<0.05). 결론: 우리의 연구는 좌심실용적, 질량 등은 안정성 협심증환자에서 QT dispersion과 유의한 상관관계를 나타냈다. 이런 소견들은 저명한 관상동맥 협착이 없는 환자들에서만 나타난다.

• Journal of Chest Surgery
• /
• 제33권10호
• /
• pp.785-791
• /
• 2000

Left ventricular dysfuction is common in immediate postoperative periods after surgical correction of heart diseases with chronic left ventricular volume overload. We speculated postoperative changes of left ventricular volume and unction in patients with patent ductus osus(PDA) who had underwent surgical repair at ages older than 16 years. Factors influencing postoperative left ventricular volume and function were also analyzed. Material and Method: From August 1989 to August 1999 thirty-siz adult patients with PDA 28 females and 8 males. were enrolled in this study. Their age ranged from 16 years to 57 years(mean :32 years). Types of surgical repair were division with primary closure in 22, division with patch closure in 6, internal obliteration using cardiopulmonary bypass in 4 and ligation in 4. Aortic clamping was combined during surgical repair in 22(61%) and cardiopulmonary bypass was used in 8(22%) Two-dimensional echocardiography studies were performed in 34(94%) preoperatively and in 25(66%) immediate postoperatively to assess postoperative changes of left ventricular internal dimensions. left ventricular volume and ejection fraction. Duration of postoperative follow-up ranged from 1 month to 99 months (mean:22 months) and 10 patients underwent 16 echocardiographic evaluation during this period Result : Preoperative and postoperative left ventricular systolic dimensions(LVIDs) were 42$\pm$8.0mm and 42$\pm$8.3mm left ventricular diastolic dimensions(LVIDd) were 64$\pm$10.0mm and 56$\pm$7.4mm left ventricular end systolic volumes(LVESV) were 62$\pm$19cc (z=1.87$\pm$0.06) and 59$\pm$24cc(z=1.78$\pm$0.08) left ventricular end diastolic volumes(LVEDL) were 169$\pm$40cc(z-1.17$\pm$0.1) and 112$\pm$29cc(z=0.85$\pm$0.1) and ejection fractions(EF) were 66$\pm$6.7% and 48$\pm$12.6% respectively. There were statistically significant differences between preoperative and postoperative values in LVDIDd(p=0.001) LVEDV(p=0.001) and EF(p=0.0001) while no significant difference is LVIDs and LVESV. Postoperative depression of ejcection fraction was significantly related with z-score of preoperative LVESV and LVEDV by univariateanalysis while LVEDV only was significant risk factor for postoperative LV dysfunction by multiple regressioin analysis ($\Delta$LVEF=-13.3-4.62$\times$LVEDV(z), p=0.001) During the follow-up periods ejection fractions become normalized in all except one patients. Conclusion ; Left ventricular function is usually deteriorated after the surgical correction of PDA in adult age and preoperative LVEDV is a major determinant of postoperative LV function.